As of August 2026, the documented U.S. change is specific: the FDA switched Differin Epiduo Acne Gel from prescription to over-the-counter status on May 22.
The change expands access to a proven combination, while the next regulatory milestone concerns generic-development guidance—not an approved generic. The gel combines adapalene 0.1%, a topical retinoid that clears clogged pores, with benzoyl peroxide 2.5%, which reduces acne-causing bacteria and inflammation. This is an access update for one product, not a broad change affecting every retinoid.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What exactly changed?
- Why does the combination matter?
- How should the OTC gel be used?
- Who needs extra caution?
- When is OTC treatment not enough?
- What should readers watch next?
What exactly changed?
The FDA prescription-to-nonprescription switch list records the approval of Differin Epiduo acne Gel on May 22, 2026. Consumers no longer need a prescription to obtain this specific adapalene and benzoyl peroxide combination. The current DailyMed label says the product is for adults and children aged 12 and older.
Children under 12 should not use it. DailyMed also lists May 22 as the start of U.S. marketing. The August update therefore concerns an already marketed OTC treatment, not a product awaiting release.
Why does the combination matter?
The switch fits established acne care. The American Academy of Dermatology's acne recommendations strongly support topical retinoids, including adapalene, and combinations involving benzoyl peroxide. The two ingredients address different parts of acne formation.
Adapalene helps clear clogged pores, while benzoyl peroxide acts on bacteria and inflammation. Galderma reports that its phase 3 trials found the combination more effective than either ingredient alone and the vehicle, meaning the gel base without active treatment. That evidence supports combining the ingredients, but it does not remove the product's irritation risks.
How should the OTC gel be used?
The labeled regimen is once daily. Applying extra gel or using it more often does not produce faster results and can increase irritation. This is an affected-area treatment rather than repeated application to individual spots throughout the day.
- Gently cleanse the affected skin.
- Apply a thin layer across the entire affected area once daily.
- Do not add extra applications in an attempt to speed treatment.
Who needs extra caution?
The label advises against using the gel on damaged or very sensitive skin. Users also need sun protection because the treatment can leave skin more vulnerable during exposure.
Pregnant or breastfeeding users should ask a doctor before using it. Anyone who develops irritation or sensitivity should stop treatment and seek advice rather than applying more product.
When is OTC treatment not enough?
Easier access does not replace escalation care. The American Academy of Dermatology recommends oral isotretinoin for severe acne or acne that has not responded to standard topical or oral treatment. That creates a practical boundary: an OTC option can simplify access to this combination, but persistent treatment failure or severe acne still calls for clinician-directed care.
What should readers watch next?
The FDA's August 21 update lists planned November 2026 product-specific guidance for generic versions of the new adapalene and benzoyl peroxide OTC reference product. That guidance would help developers design generic products. It is not a generic approval, and it does not show that an approved generic is already available.